November 2024 - Each year, we honour outstanding achievements in CML research and management by recognising exceptional lifetime contributions through the iCMLf Prizes.

Over the past 15 years, 38 extraordinary individuals—scientists, clinicians, and advocates from 14 countries have been recognised for their inspiring leadership, groundbreaking work, and lifelong dedication to improving the lives of people with CML.

We urge you to take part in preserving this proud tradition by nominating exceptional CML leaders who are most deserving of the prestigious iCMLf Prizes in 2025.

Let’s spotlight those who are CML experts and game-changers – visionaries whose work has shaped CML research and treatment globally.

ASH logo November 2024 - Only a few weeks to go until the 66th Annual Meeting of the American Society of Hematology (ASH). This year the meeting is held in San Diego, USA, and online from December 7-10^th.

With nearly 8,000 abstracts, this largest hematology event of the year is a must-attend for the latest in hematology research, including important updates on CML.

To help you plan your CML meeting schedule, we have compiled a list of sessions on CML for your convenience including oral sessions, posters presentations and a Satellite Symposium on Friday. And… don’t forget the iCMLf Forum on Advancing Treatment Free Remission globally on the 7^th December at 12pm. Register here.

Members of the iCMLf team will be on-site, so if you'd like to arrange a meeting, please reach out at info@cml-foundation.org.

We look forward to connecting with you in San Diego.

Learn more...

October 2024 - The recipients of the three 2024 iCMLf Prizes received their medals at the recent ESH-iCMLf 26th John Goldman Conference on CML: Biology and Therapy. During their acceptance speeches they shared insights into their incredible work which has significantly shaped the way we understand and treat CML today.

The keynote presentations of the 2024 prize recipients are now available to view on the iCMLf website, and they reflect the innovation, compassion, and dedication of all three prize winners across CML research, treatment, and patient advocacy.

You can listen to Professor Neil Shah’s personal view on the challenges of treatment resistance, Professor Jeff Lipton exploring the therapeutic goals of CML from the perspectives of both physicians and patients, and Viji Venkatesh share her powerful account of collaborative efforts in CML patient support and community-building.

The ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy, held in Prague, brought together world-leading experts to discuss the latest advancements in the treatment and biology of CML. Jointly organised bythe European School of Haematology (ESH) and the iCMLf , the event featured cutting-edge research presentations, insightful discussions, and collaborative sessions focused on driving innovation in CML management.

Fun Run 2024 Group picture Thanks to everyone who supported the 2024 John Goldman Fun Run, held during the recent ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy in Prague.

Despite the cold morning, the warmth of camaraderie and the fun we shared among the around 50 enthusiastic runners joining us on the 5-km route through Potviní Park made it an unforgettable experience!

Together, we raised $2,200– a heartfelt thank you to all 64 individual supporters.

The funds raised will directly support our mission to improve outcomes for people living with CML in low- and middle-income countries, ensuring that physicians in these regions can continue to access the vital training and education needed to make a difference in patient care.